Clinical Trial Update: Vorapaxar and Lower Extremity Bypass Grafts [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating Vorapaxar in patients undergoing lower extremity bypass graft procedures has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Vorapaxar (vorapaxar)

Snippet

Sponsor: Vanderbilt University | Conditions: Peripheral Artery Disease | Phase 4 | Status: WITHDRAWN